INSP · Insider Trading
Inspire Medical Systems, Inc.
Every open-market purchase and sale reported by INSP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Michael H Carrel | Director | A | +203 | +$13.82K |
| 2026-10-16 | Gary Lee Ellis | Director | A | +431 | +$29.34K |
| 2026-10-16 | Georgia Melenikiotou | Director | A | +255 | +$17.36K |
| 2026-10-16 | Shelley G Broader | Director | A | +284 | +$19.33K |
| 2026-09-02 | Jason P Kelly | See Remarks | A | +6,350 | — |
| 2026-08-11 | Jason P Kelly | See Remarks | Sell | −963 | −$57.35K |
| 2026-08-04 | Melissa Mann | Chief People Officer | F | −652 | −$56.97K |
| 2026-07-27 | Michael H Carrel | Director | A | +5,631 | — |
| 2026-07-17 | Shelley G Broader | Director | A | +383 | — |
| 2026-07-17 | Casey M Tansey | Director | A | +346 | — |
| 2026-07-17 | Georgia Melenikiotou | Director | A | +344 | — |
| 2026-07-17 | Gary Lee Ellis | Director | A | +581 | — |
| 2026-05-19 | John Rondoni | See Remarks | Sell | −2,641 | −$114.30K |
| 2026-05-15 | John Rondoni | See Remarks | Sell | −700 | −$30.11K |
| 2026-05-11 | Shawn mcCormick | Director | Sell | −696 | −$31.54K |
| 2026-05-04 | Georgia Melenikiotou | Director | MIXED | +3,512 | −$2.83K |
| 2026-05-04 | Shawn mcCormick | Director | A | +3,562 | — |
| 2026-05-04 | Shelley G Broader | Director | A | +3,562 | — |
| 2026-05-04 | Cynthia Burks | Director | A | +3,562 | — |
| 2026-05-04 | Myriam Curet | Director | A | +3,562 | — |
| 2026-05-04 | Casey M Tansey | Director | A | +3,562 | — |
| 2026-05-04 | Dana G Mead Jr. | Director | A | +3,562 | — |
| 2026-05-04 | Gary Lee Ellis | Director | A | +3,562 | — |
| 2026-04-16 | Casey M Tansey | Director | A | +308 | +$16.04K |
| 2026-04-16 | Gary Lee Ellis | Director | A | +518 | +$26.97K |
| 2026-04-16 | Georgia Melenikiotou | Director | A | +307 | +$15.99K |
| 2026-04-16 | Shelley G Broader | Director | A | +342 | +$17.81K |
| 2026-02-24 | John Rondoni | See Remarks | MIXED | +17,623 | −$43.75K |
| 2026-02-24 | Carlton Weatherby | See Remarks | MIXED | +35,119 | −$40.00K |
| 2026-02-24 | Melissa Mann | Chief People Officer | A | +15,958 | — |
| 2026-02-24 | Jason P Kelly | See Remarks | A | +15,958 | — |
| 2026-02-24 | Bryan K Phillips | See Remarks | MIXED | +26,022 | −$43.75K |
| 2026-02-24 | Timothy P. Herbert | CEO and President | MIXED | +67,148 | −$238.72K |
| 2026-02-18 | Bryan K Phillips | See Remarks | F | −579 | −$34.60K |
| 2026-02-18 | Carlton Weatherby | See Remarks | F | −570 | −$34.06K |
| 2026-02-18 | Jason P Kelly | See Remarks | F | −551 | −$32.93K |
| 2026-02-18 | John Rondoni | See Remarks | F | −587 | −$35.08K |
| 2026-02-18 | Melissa Mann | Chief People Officer | F | −615 | −$36.75K |
| 2026-02-18 | Timothy P. Herbert | CEO and President | F | −1,635 | −$97.71K |
| 2026-02-18 | Richard Buchholz | Interim CFO | F | −579 | −$34.60K |
| 2026-02-11 | Richard Buchholz | Interim CFO | F | −327 | −$21.69K |
| 2026-02-11 | John Rondoni | See Remarks | F | −327 | −$21.69K |
| 2026-02-11 | Timothy P. Herbert | CEO and President | F | −968 | −$64.21K |
| 2026-02-11 | Bryan K Phillips | See Remarks | F | −327 | −$21.69K |
| 2026-02-11 | Carlton Weatherby | See Remarks | F | −327 | −$21.69K |
| 2026-01-20 | Casey M Tansey | Director | A | +181 | +$17.46K |
| 2026-01-20 | Shelley G Broader | Director | A | +200 | +$19.29K |
| 2026-01-20 | Georgia Melenikiotou | Director | A | +180 | +$17.36K |
| 2026-01-20 | Gary Lee Ellis | Director | A | +304 | +$29.33K |
| 2026-01-12 | John Rondoni | See Remarks | Sell | −109 | −$10.90K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Timothy P. Herbert | CEO and President | 105,349 | $7.49M |
| Richard Buchholz | Interim CFO | 45,463 | $3.23M |
| Shawn mcCormick | Director | 30,712 | $2.18M |
| John Rondoni | See Remarks | 27,165 | $1.93M |
| Casey M Tansey | Director | 27,132 | $1.93M |
| Dana G Mead Jr. | Director | 26,213 | $1.86M |
| Jason P Kelly | See Remarks | 25,335 | $1.80M |
| Melissa Mann | Chief People Officer | 22,957 | $1.63M |
| Bryan K Phillips | See Remarks | 14,891 | $1.06M |
| Gary Lee Ellis | Director | 11,850 | $842.65K |
| Shelley G Broader | Director | 9,138 | $649.80K |
| Randy Ban | See Remarks | 9,136 | $649.66K |
| Georgia Melenikiotou | Director | 8,584 | $610.41K |
| Carlton Weatherby | See Remarks | 8,084 | $574.85K |
| Myriam Curet | Director | 6,927 | $492.58K |
| Cynthia Burks | Director | 6,213 | $441.81K |
| Michael H Carrel | Director | 5,834 | $414.86K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the INSP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.